MINNEAPOLIS, Feb. 23, 2021 /PRNewswire/ National Grid Renewables, which includes the renewables development company formerly known as Geronimo Energy, announced today the start of. | February 28, 2021
1 month ago
TEMPE, Ariz.–(BUSINESS WIRE)–Amkor Technology, Inc. (Nasdaq: AMKR), a leader in advanced packaging technologies that support high-growth markets, including smartphones and 5G, advanced automotive systems, high-performance computing and consumer IoT, recently unveiled new measures that help the company achieve Industry 4.0 initiatives, extending its leadership in quality and efficiency excellence.
Leveraging artificial intelligence, machine learning and interconnected systems, Industry 4.0 challenges companies to surpass factory automation and achieve factory intelligence. The goal of factory intelligence is to improve product and service quality, decision making speed on the factory floor and utilization of high-value assets.
Amkor now uses real-time, in-process decision making to drive gains in quality, asset utilization and efficiency. The application of Industry 4.0-era tools reduces cycle times for advanced packaging processing.
Mark Reynolds, Author at PopMatters popmatters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from popmatters.com Daily Mail and Mail on Sunday newspapers.
Lung Cancer Research Foundation Announces New Research Collaboration with AstraZeneca
Over $900,000 in Research Grants Focused on Resistance to EGFR Tyrosine Kinase Inhibitors (TKIs) and Immunotherapies
News provided by
Share this article
Share this article
NEW YORK, Feb. 23, 2021 /PRNewswire/ The Lung Cancer Research Foundation (LCRF) today announced a collaboration with AstraZeneca to fund over $900,000 in research grants focused on understanding resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) and immune checkpoint inhibitors (ICIs), including therapeutic approaches to overcome these mechanisms, as well as biomarkers of immune-mediated adverse events.
Lung cancer is currently the number one cause of cancer death both in the U.S. and globally among both men and women. An estimated 625 new cases are diagnosed in the U.S. every day. As research funding grows, new treatments become available and survival rates improve. Promising new treat
SparkCognition Acquires Financial Technology Company AIM2 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.